![Le Le Zhang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Le Le Zhang
Fondatore presso
CUTIA THERAPEUTICS
Patrimonio netto: 4 M $ in data 31/07/2026
Profilo
Le Le Zhang is the founder of Cutia Therapeutics, founded in 2019, holding the title of Chief Executive Officer & Executive Director since 2022.
The current job is General Manager & Director at Cutia Therapeutics (Shanghai) Co., Ltd. Education history includes a graduate degree from Shanghai Institute of Pharmaceutical Industry in 2005 and an undergraduate degree from Shenyang Pharmaceutical University in 2000.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CUTIA THERAPEUTICS 4,01% | 03/11/2025 | 15.007.236 ( 4,01% ) | 4 M $ | 31/07/2026 |
Posizioni attive di Le Le Zhang
| Società | Posizione | Inizio |
|---|---|---|
| CUTIA THERAPEUTICS | Fondatore | 15/05/2019 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Amministratore Delegato | - |
Formazione di Le Le Zhang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
36
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Shanghai Institute of Pharmaceutical Industry
 Shanghai Institute of Pharmaceutical Industry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
 Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Health Technology |
Cutia Therapeutics
 Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
